A 68-year-old man with newly diagnosed pancreatic cancer presents with sudden onset of thrombosis in multiple vascular beds (DVT, pulmonary embolism, and digital gangrene). Coagulation studies show prolonged PT/INR, prolonged aPTT, low fibrinogen, and elevated D-dimer. What is the most common underlying mechanism responsible for this prothrombotic state?

Explanation

## Cancer-Associated Thrombosis: Tissue Factor Activation **Key Point:** Tissue factor (TF) release from malignant cells is the most common mechanism driving the prothrombotic state in cancer-associated thrombosis (CAT), particularly in adenocarcinomas like pancreatic cancer. ### Mechanisms of Cancer-Associated Thrombosis | Mechanism | Frequency | Pathway Activated | Cancer Types | | --- | --- | --- | --- | | Tissue factor (TF) release | Most common | Extrinsic (Factor VII) | Adenocarcinomas (pancreas, lung, colon) | | Cancer procoagulant (CP) | Common | Bypasses Factor VII, activates Factor X directly | Various solid tumors | | Platelet activation | Common | Thrombin generation via P-selectin | All cancers | | Endothelial injury | Less common | Direct damage | Disseminated cancers | | Protein C/S deficiency | Rare | Impaired natural anticoagulation | Advanced liver disease | **High-Yield:** Adenocarcinomas (especially pancreatic, lung, and gastric) are the most thrombogenic cancers due to high TF expression on cancer cell surfaces and in cancer-derived microparticles. ### Pathophysiology of TF-Mediated Thrombosis ```mermaid flowchart TD A[Cancer cells express Tissue Factor]:::outcome --> B[TF binds Factor VII]:::action B --> C[TF-FVIIa complex formation]:::action C --> D[Activation of Factor X to Xa]:::action D --> E[Prothrombinase complex: Xa + Va + Ca2+]:::action E --> F[Thrombin generation]:::action F --> G[Fibrin clot formation]:::outcome F --> H[Platelet activation via PAR-1]:::action H --> I[Amplification of thrombosis]:::outcome I --> J[Disseminated intravascular coagulation]:::urgent ``` **Clinical Pearl:** The clinical presentation of pancreatic cancer with simultaneous venous thrombosis (DVT/PE) and arterial thrombosis (digital gangrene) is pathognomonic for disseminated intravascular coagulation (DIC) secondary to TF-driven hypercoagulability. ### Laboratory Findings in TF-Mediated CAT 1. **Prolonged PT/INR** — consumption of Factor VII (first factor activated by TF) 2. **Prolonged aPTT** — consumption of Factors VIII, IX, XI, XII 3. **Low fibrinogen** — consumption in widespread fibrin deposition 4. **Elevated D-dimer** — massive fibrin formation and degradation 5. **Thrombocytopenia** — platelet consumption in microthrombi 6. **Schistocytes on blood smear** — mechanical fragmentation of RBCs in fibrin strands **Mnemonic: CAT Mechanisms (TiPEC)** — **Ti**ssue factor (most common) > **P**latelet activation > **E**ndothelial injury > **C**oagulation factor deficiency ### Why Pancreatic Cancer is Most Thrombogenic - Highest TF expression among solid tumors - Rapid growth and extensive necrosis → TF release - High mucin production → platelet activation - Advanced stage at diagnosis → larger tumor burden - Adenocarcinoma histology → intrinsic TF expression **Warning:** Do not confuse cancer-associated thrombosis with heparin-induced thrombocytopenia (HIT), which presents with thrombocytopenia and thrombosis but has a different immune-mediated mechanism and temporal relationship to heparin exposure. [cite:Robbins 10e Ch 4]